What is Global Arteriovenous (Av) Fistula Needle Market?
The Global Arteriovenous (AV) Fistula Needle Market is a specialized sector within the healthcare industry that focuses on the production and distribution of AV fistula needles. These needles are crucial for patients undergoing hemodialysis, a treatment for kidney failure. The needles are inserted into a patient's AV fistula, a connection made by a surgeon between an artery and a vein, usually in the arm. This allows blood to be drawn from the body, cleaned by the dialysis machine, and then returned to the body. The market's value is determined by the demand for these needles, which is influenced by factors such as the prevalence of kidney disease, the number of patients requiring dialysis, and advancements in dialysis technology.
15 Gauge, 16 Gauge, 17 Gauge, Other in the Global Arteriovenous (Av) Fistula Needle Market:
The Global Arteriovenous (AV) Fistula Needle Market is segmented based on the gauge of the needle, with 15 Gauge, 16 Gauge, 17 Gauge, and other types available. The gauge refers to the size of the needle's diameter; the larger the gauge number, the smaller the needle's diameter. The choice of gauge depends on the patient's specific needs and the nature of their AV fistula. For instance, a larger gauge may be needed for patients with a larger or more robust fistula. Conversely, a smaller gauge may be more suitable for patients with a smaller or more delicate fistula. The market for each gauge is influenced by its demand, which can vary based on factors such as patient demographics, clinical guidelines, and healthcare provider preferences.
Dialysis Center, Home Dialysis, Other in the Global Arteriovenous (Av) Fistula Needle Market:
The Global Arteriovenous (AV) Fistula Needle Market finds its applications in various areas such as Dialysis Centers, Home Dialysis, and others. Dialysis Centers are the primary users of AV fistula needles, as they provide hemodialysis services to a large number of patients. Home Dialysis is another significant area of application. With advancements in healthcare technology, more and more patients are opting for home dialysis as it offers greater convenience and flexibility. Other areas of application include hospitals and clinics that offer dialysis services. The market's growth in each of these areas is influenced by factors such as the prevalence of kidney disease, the accessibility and affordability of dialysis services, and the availability of trained healthcare professionals.
Global Arteriovenous (Av) Fistula Needle Market Outlook:
Looking at the Global Arteriovenous (AV) Fistula Needle Market's outlook, it's clear that this sector is on a growth trajectory. In 2023, the market was valued at US$ 186 million. Fast forward to 2030, and it's expected to reach a value of US$ 241.1 million. This represents a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period from 2024 to 2030. It's also worth noting that the top five manufacturers in this market hold a significant share of about 65%. This indicates a high level of market concentration, with a few key players dominating the industry.
| Report Metric | Details |
| Report Name | Arteriovenous (Av) Fistula Needle Market |
| Accounted market size in 2023 | US$ 186 million |
| Forecasted market size in 2030 | US$ 241.1 million |
| CAGR | 3.7% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Nipro, Fresenius, B. Braun, Kawasumi Lab, Asahi Kasei, JMS, Bain Medical, Farmasol, Tianjin Pharma, Hongda Medical, Baihe Medical, Far East Medical, Hemoclean |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
